Tests a pharmacist follow-up service for adults starting type 2 diabetes medicine
Tests pharmacist follow-up visits for adults starting a new type 2 diabetes medicine.
Plain-language title generated from the registry record
Registry title: Effects of Medisinstart for Type 2 Diabetes
Key facts
- Where
- Åfjord, Bardufoss, Bergen, Birkeland, Brandbu, Drammen, Gjøvik, Jessheim, Kløfta, Kopervik, Lena, Nesoddtangen, Oslo, Øystese, Stavanger, Stryn, Trondheim, and Ulefoss, NorwaySee the 22 sites
Where in Norway
- Vitusapotek ÅfjordÅfjord, NorwayTaking people
- Apotek 1 AndslimoenBardufoss, NorwayTaking people
- Vitusapotek ParadisBergen, NorwayTaking people
- Birkeland apotekBirkeland, NorwayTaking people
- Apotek 1 BrandbuBrandbu, NorwayTaking people
- Sykehusapoteket i DrammenDrammen, NorwayNo longer taking part
- Vitusapotek GjøvikGjøvik, NorwayTaking people
- Vitusapotek Gotaasgaarden JessheimJessheim, NorwayTaking people
- Boots apotek KløftaKløfta, NorwayTaking people
- Apotek 1 VeakrossenKopervik, NorwayTaking people
- Apotek 1 LenaLena, NorwayTaking people
- Vitusapotek NesoddenNesoddtangen, NorwayTaking people
- Sykehusapoteket i Oslo, AkerOslo, NorwayTaking people
- Sykehusapoteket Oslo, UllevålOslo, NorwayTaking people
- Vitusapotek RøaOslo, NorwayTaking people
- Boots apotek LinneaØystese, NorwayTaking people
- Ryfylke apotekStavanger, NorwayTaking people
- Vitusapotek MarieroStavanger, NorwayTaking people
- Vitusapotek StrynStryn, NorwayNot yet recruiting
- Apotek 1 SolsidenTrondheim, NorwayTaking people
- Sykehusapoteket i TrondheimTrondheim, NorwayTaking people
- Vitusapotek UlefossUlefoss, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Apokus AS
- Trial code
- NCT06273657
- Record updated
- 28 October 2026
- Original description
Medisinstart is a counseling service in pharmacies where patients who start taking a new medicine receive two follow-up appointments with a pharmacist. The aim of the service is to promote correct medication use and increase patient adherence. The effect of Medisinstart has previously been studied among patients starting a new cardiovascular drug. The aim of the project is to map the effects of Medisinstart among patients starting a new medication for type 2 diabetes. Knowledge about the effects of Medisinstart is important in order to maximize the benefits of the service for patients and society. The project is being conducted as a randomized controlled trial among adult patients starting a new medication for type 2 diabetes. The intervention group receives Medisinstart, while the control group only receives prescription dispensing as normal. Data collection includes HbA1c analysis in blood samples and responses to questionnaires. HbA1c is an established measure of glycemic control.Read full original descriptionShow less
Effects of Medisinstart for Type 2 Diabetes
Medisinstart is a counseling service in pharmacies where patients who start taking a new medicine receive two follow-up appointments with a pharmacist. The aim of the service is to promote correct medication use and increase patient adherence. The effect of Medisinstart has previously been studied among patients starting a new cardiovascular drug. The aim of the project is to map the effects of Medisinstart among patients starting a new medication for type 2 diabetes. Knowledge about the effects of Medisinstart is important in order to maximize the benefits of the service for patients and society. The project is being conducted as a randomized controlled trial among adult patients starting a new medication for type 2 diabetes. The intervention group receives Medisinstart, while the control group only receives prescription dispensing as normal. Data collection includes HbA1c analysis in blood samples and responses to questionnaires. HbA1c is an established measure of glycemic control.
Inclusion: Extracted a new drug/active substance (A10A/A10B) for type 2 diabetes; Age ≥ 18 years; The drugs are administered by the patient/relatives; Good command of Norwegian, both written and spoken.
Exclusion: Received initiation of medication for type 2 diabetes within the last year; Ongoing participation in other studies involving similar interventions to increase adherence and ensure correct medication use; Diabetes medication is administered by a healthcare professional; HbA1c is unsuitable as an average measure of blood glucose at baseline; Inability to understand and/or complete consent forms, questionnaires and/or other patient-oriented materials; Not able to attend physical appointments in the pharmacy; Not given written consent to participate in the study; Known pregnancy.